Watchlist Price Alert

Novo Nordisk A/S (NVO)

NYSE: NVO · Real-Time Price · USD

64.35

-1.80 (-2.72%)

At close: May 16, 2025, 3:59 PM

63.94

-0.64%

After-hours: May 16, 2025, 07:59 PM EDT

Novo Nordisk A/S Statistics

Share Statistics

Novo Nordisk A/S has 4.37B shares outstanding. The number of shares has increased by -1.8% in one year.

Shares Outstanding	4.37B
Shares Change (YoY)	-1.8%
Shares Change (QoQ)	-2.35%
Owned by Institutions (%)	7.58%
Shares Floating	n/a
Failed to Deliver (FTD) Shares	2
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 25.12M, so 0.57% of the outstanding shares have been sold short.

Short Interest	25.12M
Short % of Shares Out	0.57%
Short % of Float	0.75%
Short Ratio (days to cover)	2.19

Valuation Ratios

The PE ratio is 27.33 and the forward PE ratio is 1.91. Novo Nordisk A/S's PEG ratio is 0.19.

PE Ratio	27.33
Forward PE	1.91
PS Ratio	9.5
Forward PS	0.5
PB Ratio	19.23
P/FCF Ratio	39.62
PEG Ratio	0.19

Financial Ratio History

Enterprise Valuation

Novo Nordisk A/S has an Enterprise Value (EV) of 2,846.7B.

EV / Sales	9.8
EV / EBITDA	20.72
EV / EBIT	23.53
EV / FCF	40.87

Financial Position

The company has a current ratio of 0.74, with a Debt / Equity ratio of 0.72.

Current Ratio	0.74
Quick Ratio	0.55
Debt / Equity	0.72
Debt / EBITDA	0.75
Debt / FCF	1.48
Interest Coverage	78.26

Financial Efficiency

Return on Equity is 70.38% and Return on Invested Capital is 38.99%.

Return on Equity	70.38%
Return on Assets	21.68%
Return on Invested Capital	38.99%
Revenue Per Employee	$3,751,685.92
Profits Per Employee	$1,304,653.39
Employee Count	77,406
Asset Turnover	0.62
Inventory Turnover	1.09

Taxes

Income Tax	26.2B
Effective Tax Rate	20.6%

Stock Price Statistics

The stock price has increased by -51.21% in the last 52 weeks. The beta is 0.21, so Novo Nordisk A/S's price volatility has been higher than the market average.

Beta	0.21
52-Week Price Change	-51.21%
50-Day Moving Average	68.52
200-Day Moving Average	98.37
Relative Strength Index (RSI)	45.93
Average Volume (20 Days)	9,380,253

Income Statement

In the last 12 months, Novo Nordisk A/S had revenue of 290.4B and earned 100.99B in profits. Earnings per share was 22.67.

Revenue	290.4B
Gross Profit	245.88B
Operating Income	128.34B
Net Income	100.99B
EBITDA	137.38B
EBIT	128.83B
Earnings Per Share (EPS)	22.67

Full Income Statement

Balance Sheet

The company has 15.65B in cash and 102.79B in debt, giving a net cash position of -87.13B.

Cash & Cash Equivalents	15.65B
Total Debt	102.79B
Net Cash	-87.13B
Retained Earnings	144.45B
Total Assets	489.16B
Working Capital	-61.72B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 120.97B and capital expenditures -51.31B, giving a free cash flow of 69.66B.

Operating Cash Flow	120.97B
Capital Expenditures	-51.31B
Free Cash Flow	69.66B
FCF Per Share	15.64

Full Cash Flow Statement

Margins

Gross margin is 84.67%, with operating and profit margins of 44.19% and 34.78%.

Gross Margin	84.67%
Operating Margin	44.19%
Pretax Margin	43.8%
Profit Margin	34.78%
EBITDA Margin	47.31%
EBIT Margin	44.19%
FCF Margin	23.99%

Dividends & Yields

NVO pays an annual dividend of $1.61, which amounts to a dividend yield of 2.32%.

Dividend Per Share	$1.61
Dividend Yield	2.32%
Dividend Growth (YoY)	18.21%
Payout Ratio	46.18%
Earnings Yield	3.66%
FCF Yield	2.52%

Dividend Details

Analyst Forecast

The average price target for NVO is $160, which is 148.6% higher than the current price. The consensus rating is "Buy".

Price Target	$160
Price Target Difference	148.6%
Analyst Consensus	Buy
Analyst Count	4

Stock Forecasts

Stock Splits

The last stock split was on Sep 20, 2023. It was a forward split with a ratio of 2:1.

Last Split Date	Sep 20, 2023
Split Type	forward
Split Ratio	2:1

Scores

Altman Z-Score	2.28
Piotroski F-Score	6